Hims & Hers Expands into Menopause Care Amid Patch Shortage

What’s happening

Hims & Hers Health has officially launched into the menopause care market after securing a strategic supply of estrogen patches. This expansion comes as a critical "bridge" during nationwide shortages of estradiol transdermal systems, which have been plagued by supply chain disruptions for over six months.

The shortage was triggered by a massive surge in demand following updated U.S. Preventive Services Task Force (USPSTF) guidance that highlighted broader benefits for hormone replacement therapy (HRT) in specific patient populations.

What’s changing / Business impact

• Supply Chain Arbitrage: Telehealth giants are leveraging their scale and cash reserves to secure inventory ahead of traditional retail pharmacies, effectively filling national supply gaps.
• Vertical Integration: By controlling the supply of scarce patches, Hims & Hers is moving toward a direct-to-consumer delivery model that bypasses the friction of traditional brick-and-mortar shortages.
• Market Capture: Demand for menopause treatments is rising 25% annually, significantly outpacing the legacy manufacturing capacity of traditional systems.

Why this matters

This entry proves that:

• Global supply shortages create permanent entry points for agile digital players to steal market share from legacy pharmacies.
• Telehealth is evolving from a convenience-based add-on to a core access channel for essential, scarce medications.
• Sudden demand surges (like the HRT boom) expose structural infrastructure gaps in the traditional provider-payer-pharmacy loop.